01
Actual context
Contextualized information so you understand the systems and models
US Commercialization 101
The foundations of US healthcare made easy to understand for entrepreneurs wanting the most important basics
Register nowUS Commercialization 101 · virtual course
See the agendaTwo virtual 3-hour sessions · 2 & 3 November 2026
€299 for both days · Register by 30 October 2026US healthcare made easy to understand
The foundations of US healthcare made easy to understand for entrepreneurs wanting the most important basics
Learn how the spectrum of US healthcare systems work, from fee-for-service to value-based care and all that sits between.
You’ll leave equipped to determine where your business has the best potential impact in the US
The essentials applied to what you need to know most: how to determine your GTM; structure your business model to make early revenue easier; and how to read the landscape so you can be surprisingly efficient.
02
Objective and based on what's happening on the ground in 2026 (and what we see coming up in 2027)
Nothing is sugarcoated here. You’ll learn how this really works.
03
Case studies
Real-world case studies covering revenue and disruptive tech
Applied to action
Straight to the point for entrepreneurs with limited time and bandwidth
From open discussions to working real-world case studies together, we apply what matters most—and how to think about incentives, procurement, and competitive edges in different models—so you can spend your time efficiently. We cover theory but applied to action, alongside what you can expect when you prepare for delegations and market visits, translating pilots to adoptions, and how to think about generating revenue pre-reimbursement.
01 / 03
November 2026
Course Schedule
These sessions are designed based on the last decade of what European companies need to know to scale into the US in an effective manner: where and how the value propositions are actually adoptable, what evidence from European markets tends to resonate, and how to make decisions on the go. The course is appropriate for those who are evaluating the opportunity of going to the US and are in the early stages of planning; this will give you the fundamentals of deciding go/no-go to the US (and if “go” how to do so).
You won’t learn everything about the US market, but you’ll learn what you need to determine your next steps based on the real-world landscape of 2026.
- 0113:00–16:00 CET
Translating European evidence into US adoption
- Presenting clinical evidence with demographic differences
- Contextualizing workflow and service line efficiencies
- When US systems care about cost savings
- Framing welfare and access to care in US context
- What kind of sites for the first US pilot are most equipped to agree
- 0213:00–16:00 CET
Revenue before Reimbursement
- Making the case before you have a CPT code
- Determining payer mixes and if fee-for-service is a good fit for your business
- What models exist in the US that most closely align with those in Finland, Sweden, Estonia, and Germany
- Developing parallel revenue streams based on cost savings and quality outcomes rather than throughput
- What opportunities to participate in large payer programs in 2027
All sessions are held virtually · 13:00–16:00 CET · €299 for both days · Registration closes 30 October 2026
FAQs
01Who is this course for?
European healthcare entrepreneurs who want to get an intense, accurate understanding of the US market as it relates to their commercial planning. If you have a passing familiarity with the US healthcare market, this will help you contextualize quite a lot.
02What makes this for European entrepreneurs?
Unlike courses that just teach the same endless sprawl (you know the drill: reimbursement overviews that are just acronyms from consultants, legal overviews that are really pitches from law firms, etc), this is designed to help European companies find commercial success in the US.
This is true around the world, but this course is aligned with models from the UK to Estonia and made compatible with those time zones.
- European healthcare models value and incentivize things differently, which means that what’s successful in Finland or Germany will have a different value shape and a different business model.
- These value props and models don’t line up with most of traditional US healthcare. Unfortunately, most US organizations don’t realize this because they aren’t familiar with how systems outside of the US work. They try to force US models that either don’t reflect the value prop rewarded in the home market or they guide companies into a long cycle that is expensive and doesn’t ultimately reward a competitive advantage.
03Do I need to be ready to scale to the US?
No, in fact, this course is most useful to you 6–12 months before you think you might want to approach the US. The reason being twofold:
- You’ll learn how to target to your value proposition and economic model (which may not be going to reimbursement first!)—and this will inform any remaining studies and pilots you may be doing in the meantime.
- This course shows what really happens in the trenches: what gets adopted, how, and why. The US may or may not be your next best economic move. This course will help you determine how to order your market expansion by cost-of-acquisition and opportunity.
04Reimbursement codes exist for my product, so we’re ready to go after FDA, right?
Unfortunately, no. There’s still a process, but that’s table stakes. The bigger challenge is knowing if—once your product gets established, billed, and covered—the code offers a margin that makes it worthwhile for adoption; a lot of codes don’t get through coverage and have inadequate payment (so the system still loses money to use the device).
The more important area is where the value proposition aligns with how that system makes and spends money. If it’s on saving costs, improving quality outcomes (like preventing negative consequences), or improving workflow/speed/efficiency, those align with different business models. Your reason for adoption needs to be reflected in the revenue, and focusing first on CPT codes may or may not do it.
05Do I need to know anything first?
No, just come with the willingness to absorb a lot of information quickly, work case studies, ask critical questions, and put the material to work. No knowledge of healthcare systems is assumed.
06Does this course teach everything I’ll need to know?
Of course not. But it will give you a very practical understanding of how the US landscape works and the key information you’ll need to know to make informed commercial decisions. For deep dives, we offer courses you can take quickly in specific areas you feel you need more insight, such as our Pricing and Profit class that reveals the wild way margins work on the other side of reimbursement and value-based contracting. The next step would be to apply to the Boardroom, which is for companies actively scaling into the US.
07How much time does it take?
Two virtual 3-hour sessions on 2 and 3 November 2026, 13:00–16:00 CET.
Instead of teaching everything you might ever need to know, this is very specific to what’s useful to healthtech entrepreneurs evaluating their commercial opportunities. Basically, we took all the fluff out. No one has time for that.
You can expect to spend about an hour after each session reviewing the material and mentally preparing for the next. We’ll work through real-world case studies and apply information to your own companies. How much you put into it is up to you; what you put in is what you get out of it.
08How much is it?
It’s €299 for both days. We offer group discounts for 3 or more (email through the contact form or to Elizabeth directly). We also offer discount codes to our partners for their companies. You can always email us to check if your trade agency, cluster, science park, or university have partnered for a code.
09Does this cover biotech?
This course is applicable to everyone in:
- Medtech (medical devices)
- Software / digital health
- Biotech / pharma
10Where can I ask other questions?
Reach out here and we’ll get back to you as soon as possible.
Other courses that might interest you…
Uncertainty + Decision-Making under Fire
Learn how to make high-stakes decisions with incomplete information under pressure. We share a practical decision framework to think about risk, uncertainty, and how to manage short- and long-term situations that continue to evolve.
Next offering will be January 2027
Info + RegistrationProfit + Pricing in US Healthcare
This is a straightforward and intense workshop covering pricing, margins, and payer mixes. You’ll leave with an understanding of how the real calculus works, what figures come with risky caveats, and how to structure your asks.
Next offering will be January 2027
Info + RegistrationThe next step
Start with the right foundations.
Join both course days on November 2 and 3, 2026, from 13:00–16:00 CET. Register by October 30; €299 for individual access to both days.
Start a conversationRegister now